Biology › Practise › Questions › Stem cells and cell potency
Questions on stem cells and cell potency
What a stem cell is and what self-renewal means, the four levels of potency from totipotent to unipotent with a real example of each, the four sources stem cells are obtained from and the potency each one gives, induced pluripotent cells and what they show about the genome, why differentiation switches genes off rather than removing them, the treatments already in use and those still only proposed, and the positions people hold on the use of embryos.
15 original questions · 51 marks · the stem cells and cell potency notes · Cell cycles, reproduction and development
To print: the questions (PDF, 53 KB) · the mark schemes (PDF, 62 KB)
Every question here is written for this library rather than taken from a past paper. Write your answer out before opening a mark scheme: the schemes award marks point by point, and the points are much easier to see when you have something of your own to compare against.
Evaluate the use of embryonic stem cells as a source of cells for treating human disease.
Mark scheme
- B1 for: embryonic stem cells are pluripotent, so a far wider range of tissues can be produced from them than from adult or cord blood cells
- B1 for: they divide in culture apparently without limit, so one cell line can supply large numbers of cells, and they offer treatment for conditions with no present cure
- B1 against: obtaining them ends the development of a blastocyst, which some hold to be a human individual from fertilisation, so that no benefit to a patient can justify it
- B1 against: the cells come from another individual and may be rejected, and undifferentiated cells remaining in a transplant may form tumours
- B1 alternatives: adult and umbilical cord blood cells raise no such objection but are multipotent, and induced pluripotent cells offer pluripotency from the patient's own tissue without using an embryo
- A1 a judgement is stated and supported by the points made above it; credit either conclusion provided the reasoning leads to it
Describe what is meant by totipotent, pluripotent, multipotent and unipotent, giving one example of a cell at each level.
Mark scheme
- B1 totipotent: can become every cell type of the organism and the extra-embryonic tissues, for example a zygote or a cell of the first few divisions
- B1 pluripotent: can become every cell type of the body but not extra-embryonic tissue, for example a cell of the inner cell mass of a blastocyst
- B1 multipotent: can become a limited number of related types, for example a haematopoietic stem cell in bone marrow, which forms blood cells
- B1 unipotent: can become one type only, for example the cells that give rise to new cardiomyocytes in heart muscle
Induced pluripotent stem cells are made by treating an adult body cell with four transcription factors. Discuss the advantages and the limitations of using these cells rather than embryonic stem cells.
Mark scheme
- B1 advantage: no embryo is used, so the ethical objection to ending the development of a blastocyst does not apply
- B1 advantage: the cells can be made from the patient's own tissue, so they carry the patient's own antigens and the risk of rejection is much lower
- B1 limitation: reprogramming succeeds in only a small proportion of the cells treated, and methods that insert the genes using a virus increase the risk of tumours
- B1 limitation: induced pluripotent cells have not been shown to be equivalent to embryonic cells, which are still used as the standard for comparison
Compare embryonic stem cells with induced pluripotent stem cells as a source of cells for medical treatment, referring to their potency, where each comes from, and the ethical objection each raises.
Mark scheme
- B1 both are pluripotent, able to become any cell type of the body, whereas cells taken from adult tissue or cord blood are only multipotent
- B1 embryonic stem cells are taken from the inner cell mass of a blastocyst, whereas induced pluripotent cells are made by reprogramming an ordinary body cell, such as a skin fibroblast, with four transcription factors
- B1 obtaining embryonic stem cells ends the development of the blastocyst, which raises the ethical objection that a human embryo is destroyed, whereas induced pluripotent cells are made without an embryo and so do not raise that objection
- A1 induced pluripotent cells can also be made from the patient's own tissue, so they are not rejected by the patient's immune system, whereas embryonic stem cells come from another individual and may be rejected
Outline two pieces of evidence that show a specialised cell retains a complete set of genes even though it does not express them all.
Mark scheme
- B1 in 1996 the nucleus from an adult sheep's mammary gland cell was transferred into an enucleated egg cell, and the resulting embryo developed into a normal sheep, showing the nucleus still held every gene needed to build a whole animal
- B1 the specialised mammary gland cell could not have produced a whole sheep on its own, so this outcome depended on the recipient egg's cytoplasm reprogramming the transferred nucleus
- B1 in 2006, treating an adult mouse fibroblast with four transcription factors returned it to a pluripotent state, and human cells were shown to respond the same way the following year
- B1 the four genes delivered were extra copies of genes the fibroblast already carried, so reprogramming worked by switching the cell's existing genes back on rather than by adding new genetic information
Explain why researchers in the United Kingdom are not permitted to grow a human embryo in culture beyond fourteen days after fertilisation.
Mark scheme
- B1 research on human embryos in the UK requires a licence from the Human Fertilisation and Embryology Authority and the consent of the donors
- B1 the limit is set at fourteen days because that is when the primitive streak appears
- B1 before the primitive streak forms, the embryo can still split to give twins, so there is not yet a single developing individual
- A1 the primitive streak is treated as a landmark at which a line can reasonably be drawn, though some hold that a line drawn at any developmental landmark is arbitrary
Identify which of the following are established stem cell treatments and which are still at the trial or research stage: a bone marrow transplant for leukaemia, a skin graft for burns grown from the patient's own cells, insulin-secreting cells for type 1 diabetes, and dopamine-secreting neurones for Parkinson's disease.
Mark scheme
- B1 a bone marrow transplant for leukaemia is an established treatment, in routine clinical use for decades
- B1 a skin graft for burns grown from the patient's own epidermal stem cells is an established treatment
- B1 insulin-secreting cells for type 1 diabetes are still at the trial stage, not yet a routine treatment
- B1 dopamine-secreting neurones for Parkinson's disease are also still at the trial stage, not yet a routine treatment
A neurone contains the gene coding for insulin but never produces insulin. Explain how this is possible.
Mark scheme
- B1 all body cells are derived by mitosis from the same zygote, so they contain the same genes
- B1 cells differentiate by transcribing some genes and not others, rather than by losing genes
- A1 in a neurone the insulin gene is not transcribed, so no mRNA and no insulin is produced from it, although the gene is present and intact
Compare stem cells obtained from adult bone marrow with stem cells obtained from an early embryo.
Mark scheme
- B1 bone marrow cells are multipotent and can form only blood cells, whereas embryonic cells are pluripotent and can form any cell type of the body
- B1 bone marrow cells can be taken from the patient themselves so carry the patient's own antigens and are far less likely to be rejected, whereas embryonic cells come from another individual and may be rejected
- B1 obtaining bone marrow cells does not end the development of an embryo, whereas obtaining embryonic cells does, so the two raise different ethical objections
A patient is treated with nerve cells that have been grown from embryonic stem cells. Suggest three difficulties that this treatment may present.
Mark scheme
- B1 any cells that have not differentiated may continue to divide after transplant and form a tumour
- B1 the cells carry antigens from another individual, so they may be rejected by the patient's immune system unless immunosuppressant drugs are given
- B1 it is difficult to control differentiation so that only the required cell type is produced, and difficult to make the cells connect correctly with existing tissue
A cell population is unspecialised and divides without limit, but none of its cells ever differentiate. Explain why this population would not function as a useful source of stem cells for tissue replacement, and explain why transplanting it into a patient could do harm.
Mark scheme
- B1 a stem cell must be able to differentiate as well as renew itself, because differentiation is what replaces the specialised cells the tissue actually needs
- B1 a population that only self-renews and never differentiates would form a growing mass of unspecialised cells rather than a tissue
- A1 cells transplanted into a patient that go on dividing without differentiating can form a tumour, the same risk that undifferentiated cells left behind in any stem cell transplant carry
A single parenchyma cell taken from a carrot root can be grown in culture into a complete new carrot plant, but a single skin cell taken from a human cannot be grown into a complete new human. Explain this difference.
Mark scheme
- B1 the carrot root cell is totipotent, retaining the ability to form every cell type of the plant
- B1 in most plants, unlike in most animals, a differentiated somatic cell can be induced to revert to a totipotent state and, given the right conditions, regenerate a whole new organism
- A1 the human skin cell is only unipotent or, at most, multipotent, since differentiation in an animal removes access to earlier developmental programmes far more completely than it does in a plant cell
Cord blood collected at a birth is frozen and stored rather than used immediately. Suggest one advantage of collecting stem cells this way rather than from adult bone marrow, and suggest the main limitation on how the stored cells could later be used.
Mark scheme
- B1 collection at birth carries no risk to the mother or the infant, unlike aspirating bone marrow from an adult donor under anaesthetic
- B1 the cells can be frozen and stored for years, so they are available immediately when needed rather than requiring a fresh donation
- A1 the main limitation is quantity: one cord yields only a small volume of blood, which may hold too few cells to treat an adult patient
State the two properties a cell must have if it is to be described as a stem cell.
Mark scheme
- B1 it is unspecialised and can differentiate into one or more specialised cell types
- B1 it can divide repeatedly by mitosis to produce more cells like itself, which is self-renewal
A cell is removed from the inner cell mass of a five-day-old human blastocyst. Name the level of potency this cell shows.
Mark scheme
- B1 pluripotent; totipotent is not accepted, because the cell cannot form extra-embryonic tissue such as the placenta
Practise stem cells and cell potency one question at a time
The player marks nothing for you. It shows one question, waits, then shows the scheme so you can mark yourself, and brings a question back sooner when it went badly.